Publication: Outcomes of descemet membrane endothelial keratoplasty in bangkok, thailand
Issued Date
2021-01-01
Resource Type
ISSN
11775483
11775467
11775467
Other identifier(s)
2-s2.0-85107974990
Rights
Mahidol University
Rights Holder(s)
SCOPUS
Bibliographic Citation
Clinical Ophthalmology. Vol.15, (2021), 2239-2251
Suggested Citation
Kaevalin Lekhanont, Punyanuch Pisitpayat, Nontawat Cheewaruangroj, Passara Jongkhajornpong, Manachai Nonpassopon, Thunyarat Anothaisintawee Outcomes of descemet membrane endothelial keratoplasty in bangkok, thailand. Clinical Ophthalmology. Vol.15, (2021), 2239-2251. doi:10.2147/OPTH.S310873 Retrieved from: https://repository.li.mahidol.ac.th/handle/20.500.14594/78705
Research Projects
Organizational Units
Authors
Journal Issue
Thesis
Title
Outcomes of descemet membrane endothelial keratoplasty in bangkok, thailand
Other Contributor(s)
Abstract
Purpose: To investigate the medium-term clinical outcomes and risk factors for primary graft failure after Descemet membrane endothelial keratoplasty (DMEK) in Thai patients. Patients and Methods: This is a single-center retrospective cohort study. Sixty-two eyes of 62 patients who underwent DMEK at Ramathibodi Hospital, Bangkok, Thailand, with a minimum of 24-month follow-up were recruited. Preoperative donor and recipient char-acteristics, intraoperative data, and postoperative outcomes including best-corrected visual acuity (BCVA), graft clarity, endothelial cell density (ECD), central corneal thickness (CCT), and complications were evaluated at 1, 3, 6, 12, and 24 months after surgery. Results: The mean age of the patients was 67.2 ± 9.9 years, and 52% were female. The mean follow-up time was 37.5 ± 11.0 months. The most common indications for DMEK were Fuchs’ endothelial corneal dystrophy (FECD) (53.2%) and pseudophakic bullous keratopathy (PBK) (17.7%). Nearly half of patients had triple-DMEK. The median preoperative BCVA was 20/400. Postoperative BCVA of ≥ 20/40 was reached in 37.1% and of ≥ 20/20 in 6.5% after 1 month which increased to 54.8% and 17.7% after 3 months; and to 67.7% and 27.4% after 24 months. Endothelial cell loss (ECL) at 3, 6, 12, and 24 months was 30.5%, 33.8%, 44.4%, and 45.9%, respectively. Graft diameter was the single factor, showing a significant relationship with postoperative ECD. Most frequent postoperative complications included graft detachment (22.6%), increased IOP/glaucoma (17.7%), and primary graft failure (16.1%). In univariate analysis, death-to-operation time and the diagnosis of PBK were significantly associated with the occurrence of primary graft failure. Conclusion: DMEK is a safe, effective, and feasible treatment for endothelial failure in Asian eyes. Careful case selection, use of relatively fresh donor tissues, and appropriate surgical techniques can prevent primary graft failure and facilitate optimal outcomes following surgery.